173 related articles for article (PubMed ID: 33295096)
1. MBNL1 regulates isoproterenol-induced myocardial remodelling in vitro and in vivo.
Xu Y; Liang C; Luo Y; Zhang T
J Cell Mol Med; 2021 Jan; 25(2):1100-1115. PubMed ID: 33295096
[TBL] [Abstract][Full Text] [Related]
2. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy.
Wang K; Long B; Zhou J; Li PF
J Biol Chem; 2010 Apr; 285(16):11903-12. PubMed ID: 20177053
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of myocardial hypertrophy regulated by the interaction between mhrt and myocardin.
Luo Y; Xu Y; Liang C; Xing W; Zhang T
Cell Signal; 2018 Mar; 43():11-20. PubMed ID: 29199045
[TBL] [Abstract][Full Text] [Related]
4. LncRNA-Mhrt regulates cardiac hypertrophy by modulating the miR-145a-5p/KLF4/myocardin axis.
Xu Y; Luo Y; Liang C; Zhang T
J Mol Cell Cardiol; 2020 Feb; 139():47-61. PubMed ID: 31982428
[TBL] [Abstract][Full Text] [Related]
5. Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity.
Yoshida T; Yamashita M; Horimai C; Hayashi M
J Biol Chem; 2014 Sep; 289(38):26107-26118. PubMed ID: 25100730
[TBL] [Abstract][Full Text] [Related]
6. HuR regulates phospholamban expression in isoproterenol-induced cardiac remodelling.
Hu H; Jiang M; Cao Y; Zhang Z; Jiang B; Tian F; Feng J; Dou Y; Gorospe M; Zheng M; Zheng L; Yang Z; Wang W
Cardiovasc Res; 2020 Apr; 116(5):944-955. PubMed ID: 31373621
[TBL] [Abstract][Full Text] [Related]
7. Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation.
Grisanti LA; Repas AA; Talarico JA; Gold JI; Carter RL; Koch WJ; Tilley DG
Am J Physiol Heart Circ Physiol; 2015 Feb; 308(4):H316-30. PubMed ID: 25485901
[TBL] [Abstract][Full Text] [Related]
8. Zinc Finger Protein ZBTB20 protects against cardiac remodelling post-myocardial infarction via ROS-TNFα/ASK1/JNK pathway regulation.
Li F; Yang Y; Xue C; Tan M; Xu L; Gao J; Xu L; Zong J; Qian W
J Cell Mol Med; 2020 Nov; 24(22):13383-13396. PubMed ID: 33063955
[TBL] [Abstract][Full Text] [Related]
9. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.
Hong HQ; Lu J; Fang XL; Zhang YH; Cai Y; Yuan J; Liu PQ; Ye JT
Acta Pharmacol Sin; 2018 Feb; 39(2):184-194. PubMed ID: 28816235
[TBL] [Abstract][Full Text] [Related]
10. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
[TBL] [Abstract][Full Text] [Related]
11. MiR-466h-5p induces expression of myocardin with complementary promoter sequences.
Luo Y; Liang C; Xu Y; Zhang T
Biochem Biophys Res Commun; 2019 Jun; 514(1):187-193. PubMed ID: 31029421
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of β-Adrenoceptors in Isoproterenol-Induced Cardiac Remodeling through HuR.
Yin Q; Yang C; Wu J; Lu H; Zheng X; Zhang Y; Lv Z; Zheng X; Li Z
PLoS One; 2016; 11(4):e0152005. PubMed ID: 27035432
[TBL] [Abstract][Full Text] [Related]
13. p300 protein as a coactivator of GATA-5 in the transcription of cardiac-restricted atrial natriuretic factor gene.
Kakita T; Hasegawa K; Morimoto T; Kaburagi S; Wada H; Sasayama S
J Biol Chem; 1999 Nov; 274(48):34096-102. PubMed ID: 10567378
[TBL] [Abstract][Full Text] [Related]
14. MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.
Mehta G; Kumarasamy S; Wu J; Walsh A; Liu L; Williams K; Joe B; de la Serna IL
J Mol Cell Cardiol; 2015 Nov; 88():101-10. PubMed ID: 26388265
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling.
Vigil-Garcia M; Demkes CJ; Eding JEC; Versteeg D; de Ruiter H; Perini I; Kooijman L; Gladka MM; Asselbergs FW; Vink A; Harakalova M; Bossu A; van Veen TAB; Boogerd CJ; van Rooij E
Cardiovasc Res; 2021 May; 117(6):1532-1545. PubMed ID: 32717063
[TBL] [Abstract][Full Text] [Related]
16. Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart.
Webb IG; Nishino Y; Clark JE; Murdoch C; Walker SJ; Makowski MR; Botnar RM; Redwood SR; Shah AM; Marber MS
Cardiovasc Res; 2010 Aug; 87(3):494-503. PubMed ID: 20299330
[TBL] [Abstract][Full Text] [Related]
17. Neuron-derived orphan receptor-1 modulates cardiac gene expression and exacerbates angiotensin II-induced cardiac hypertrophy.
Cañes L; Martí-Pàmies I; Ballester-Servera C; Herraiz-Martínez A; Alonso J; Galán M; Nistal JF; Muniesa P; Osada J; Hove-Madsen L; Rodríguez C; Martínez-González J
Clin Sci (Lond); 2020 Feb; 134(3):359-377. PubMed ID: 31985010
[TBL] [Abstract][Full Text] [Related]
18. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R
Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892
[TBL] [Abstract][Full Text] [Related]
19. Modulation of angiotensin II-mediated cardiac remodeling by the MEF2A target gene Xirp2.
McCalmon SA; Desjardins DM; Ahmad S; Davidoff KS; Snyder CM; Sato K; Ohashi K; Kielbasa OM; Mathew M; Ewen EP; Walsh K; Gavras H; Naya FJ
Circ Res; 2010 Mar; 106(5):952-60. PubMed ID: 20093629
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 family of cytokines mediates isoproterenol-induced delayed STAT3 activation in mouse heart.
Yin F; Li P; Zheng M; Chen L; Xu Q; Chen K; Wang YY; Zhang YY; Han C
J Biol Chem; 2003 Jun; 278(23):21070-5. PubMed ID: 12665506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
